ROLE OF ANTIDEPRESSANTS AGAINST LEISHMANIASIS
DOI:
https://doi.org/10.22159/ijpps.2022v14i3.43662Keywords:
Leishmania, Antidepressants, Drug resistance, Tricyclics antidepressantsAbstract
The disease, Leishmaniasis is a forlorn, tropical, vector-borne disease caused by the kinetoplast protozoan, an obligate intracellular parasite of the class Leishmania, which is transmitted by the nibble of female sandfly (Phlebotomus). Leishmaniasis is an incurable rare disease, since the organism developed resistance towards the currently used drugs, including pentavalent antimonials, amphotericin B and miltefosine. The mechanisms involved in drug resistance include reduced expression and mutations in AQP1, mutations in miltefosine transporters like, LMT and/or LRos3 and increased expression of drug efflux transporters like, ABC transporters in the parasitic cells. Hence alternate therapeutics against leishmaniasis is the need of the hour. Here we discuss the therapeutic potential of antidepressants as potential antileishmanial agents.
Downloads
References
Kumar GA, Karmakar J, Mandal C, Chattopadhyay A. Leishmania donovani internalizes into host cells via caveolin-mediated endocytosis. Sci Rep. 2019;9(1):12636. doi: 10.1038/s41598-019-49007-1, PMID 31477757.
De Freitas EO, Leoratti FMdS, Freire-de-Lima CG, Morrot A, Feijo DF. The contribution of evasive immune mechanisms to parasite persistence in visceral leishmaniasis. Front Immunol. 2016;7:153. doi: 10.3389/fimmu.2016.00153, PMID 27148272.
Manhas R, Tandon S, Sen SS, Tiwari N, Munde M, Madhubala R. Leishmania donovani parasites are inhibited by the benzoxaborole AN2690 targeting leucyl-tRNA synthetase. Antimicrob Agents Chemother. 2018;62(9):e00079-18. doi: 10.1128/AAC.00079-18, PMID 29941647.
Kariyawasam KKGDUL, Selvapandiyan A, Siriwardana HVYD, Dube A, Karunanayake P, Senanayake SASC, Dey R, Gannavaram S, Nakhasi HL, Karunaweera ND. Dermotropic leishmania donovani in Sri Lanka: visceralizing potential in clinical and preclinical studies. Parasitology. 2018;145(4):443-52. doi: 10.1017/S003118201700169X, PMID 29113609.
Savoia D. Recent updates and perspectives on leishmaniasis. J Infect Dev Ctries. 2015;9(6):588-96. doi: 10.3855/jidc.6833, PMID 26142667.
Morimoto A, Uchida K, Chambers JK, Sato K, Hong J, Sanjoba C, Matsumoto Y, Yamagishi J, Goto Y. Hemophagocytosis induced by Leishmania donovani infection is beneficial to parasite survival within macrophages. PLOS Negl Trop Dis. 2019;13(11):e0007816. doi: 10.1371/journal.pntd.0007816. PMID 31738750.
Garrido Jareno M, Sahuquillo Torralba A, Chouman Arcas R, Castro Hernandez I, Molina Moreno JM, Llavador Ros M, Gomez Ruiz MD, Lopez Hontangas JL, Botella Estrada R, Salavert Lleti M, Peman Garcia J. Cutaneous and mucocutaneous leishmaniasis: experience of a mediterranean hospital. Parasit Vectors. 2020;13(1):24. doi: 10.1186/s13071-020-3901-1, PMID 31931865.
Bouazizi Ben Messaoud HB-B, Guichard M, Lawton P, Delton I, Azzouz Maache S. Changes in lipid and fatty acid composition during intramacrophagic transformation of Leishmania donovani complex promastigotes into amastigotes. Lipids. 2017;52(5):433-41. doi: 10.1007/s11745-017-4233-6, PMID 28161835.
Lockard RD, Wilson ME, Rodriguez NE. Sex-related differences in immune response and symptomatic manifestations to infection with leishmania species. J Immunol Res. 2019;2019:4103819. doi: 10.1155/2019/4103819, PMID 30756088.
Rodrigues V, Cordeiro-da-Silva A, Laforge M, Silvestre R, Estaquier J. Regulation of immunity during visceral leishmania infection. Parasit Vectors. 2016;9(1):118. doi: 10.1186/s13071-016-1412-x, PMID 26932389.
Van Griensven J, Diro E. Visceral leishmaniasis: recent advances in diagnostics and treatment regimens. Infect Dis Clin North Am. 2019;33(1):79-99. doi: 10.1016/j.idc.2018.10.005, PMID 30712769.
Peters NC, Egen JG, Secundino N, Debrabant A, Kimblin N, Kamhawi S, Lawyer P, Fay MP, Germain RN, Sacks D. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science. 2008;321(5891):970-4. doi: 10.1126/science.1159194, PMID 18703742.
Ribeiro-de-Jesus A, Almeida RPd, Lessa H, Bacellar O, Carvalho EM. Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res. 1998;31(1):143-8. doi: 10.1590/s0100-879x1998000100020, PMID 9686192.
Ohjijcpr EG. An overview of the azoles of interest. Int J Curr Pharm Res. 2015;7(1):1-6.
Hendrickx S, Guerin PJ, Caljon G, Croft SL, Maes L. Evaluating drug resistance in visceral leishmaniasis: the challenges. Parasitology. 2018;145(4):453-63. doi: 10.1017/ S0031182016002031, PMID 27866478.
Regli IB, Fernandez OL, Martinez Salazar B, Gomez MA, Saravia NG, Tacchini Cottier F. Resistance of leishmania (Viannia) panamensis to meglumine antimoniate or miltefosine modulates neutrophil effector functions. Front Immunol. 2018;9:3040. doi: 10.3389/fimmu.2018.03040, PMID 30622537.
Ghorbani M, Farhoudi R. Leishmaniasis in humans: drug or vaccine therapy? Drug Des Dev Ther. 2018;12:25-40. doi: 10.2147/DDDT.S146521. PMID 29317800.
Bérard A, Zhao JP, Sheehy O. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the quebec pregnancy cohort. BMJ Open. 2017;7(1):e013372. doi: 10.1136/bmjopen-2016-013372, PMID 28082367.
Chakravarty J, Sundar S. Drug resistance in leishmaniasis. J Glob Infect Dis. 2010;2(2):167-76. doi: 10.4103/0974-777X.62887, PMID 20606973.
Sundar S, Singh A, Rai M, Prajapati VK, Singh AK, Ostyn B, Boelaert M, Dujardin JC, Chakravarty J. Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clin Infect Dis. 2012;55(4):543-50. doi: 10.1093/cid/cis474, PMID 22573856.
Dorlo TP, Balasegaram M, Beijnen JH, de Vries PJ. Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. J Antimicrob Chemother. 2012;67(11):2576-97. doi: 10.1093/jac/dks275, PMID 22833634.
Sundar S, Thakur BB, Tandon AK, Agrawal NR, Mishra CP, Mahapatra TM, Singh VP. Clinicoepidemiological study of drug resistance in Indian kala-azar. BMJ. 1994;308(6924):307. doi: 10.1136/bmj.308.6924.307, PMID 8124119.
Sundar S, Murray HW. Availability of miltefosine for the treatment of kala-azar in India. Bull World Health Organ. 2005;83(5):394-5. doi: /S0042-96862005000500018, PMID 15976883.
Sundar S, Sinha PR, Agrawal NK, Srivastava R, Rainey PM, Berman JD, Murray HW, Singh VP. A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate. Am J Trop Med Hyg. 1998;59(1):139-43. doi: 10.4269/ajtmh.1998.59.139, PMID 9684642.
Andrade Neto VV, Pereira TM, do Canto Cavalheiro Md, Torres Santos EC. Imipramine alters the sterol profile in leishmania amazonensis and increases its sensitivity to miconazole. Parasit Vectors. 2016;9(1):183. doi: 10.1186/s13071-016-1467-8, PMID 27036654.
Marquis N, Gourbal B, Rosen BP, Mukhopadhyay R, Ouellette M. Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania. Mol Microbiol. 2005;57(6):1690-9. doi: 10.1111/j.1365-2958.2005.04782.x. PMID 16135234.
Légaré D, Richard D, Mukhopadhyay R, Stierhof YD, Rosen BP, Haimeur A, Papadopoulou B, Ouellette M. The leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase. J Biol Chem. 2001;276(28):26301-7. doi: 10.1074/jbc.M102351200. PMID 11306588.
Ashutosh, Sundar S, Goyal N. Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol. 2007;56(2):143-53. doi: 10.1099/jmm.0.46841-0. PMID 17244793.
Ponte Sucre A, Gamarro F, Dujardin JC, Barrett MP, Lopez Velez R, Garcia Hernandez R, Pountain AW, Mwenechanya R, Papadopoulou B. Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLOS Negl Trop Dis. 2017;11(12):e0006052. doi: 10.1371/journal.pntd.0006052. PMID 29240765.
Meleppurakkal S, KS, DJ. Effect of selected yoga techniques along with ashwagandha and vacha in depression in the age group 65–75 YEARS. Asian J Pharm Clin Res 2021;14:65-8. doi: 10.22159/ajpcr.2021.v14i11.42259.
Alvano SA, Zieher LM. An updated classification of antidepressants: A proposal to simplify treatment. Personalized Medicine in Psychiatry. 2020;19-20. doi: 10.1016/j.pmip.2019.04.002.
Rani S, Sindhu N, Saini R, Pandey AK, Narwat A, Garg S. Comparison of the effects of antidepressants on cognition functions in patients of major depressive disorders in tertiary care hospital in haryana. Asian J Pharm Clin Res 2021;14:134-40. doi: 10.22159/ajpcr.2021.v14i3.40467.
Obonaga R, Fernandez OL, Valderrama L, Rubiano LC, Castro Mdel M, Barrera MC, Gomez MA, Gore Saravia N. Treatment failure and miltefosine susceptibility in dermal leishmaniasis caused by Leishmania subgenus Viannia species. Antimicrob Agents Chemother. 2014;58(1):144-52. doi: 10.1128/AAC.01023-13, PMID 24145529.
Chen JY, Ren Y, Yan P, Belina ME, Chung RT, Butt AA. Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C‐infected persons: results from erchives. J Viral Hepat. 2018;25(7):825-33. doi: 10.1111/jvh.12884, PMID 29478294.
Quillin III RC, Wilson GC, Nojima H, Freeman CM, Wang J, Schuster RM, Blanchard JA, Edwards MJ, Gandhi CR, Gulbins E, Lentsch AB. Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice. Hepatol Res. 2015;45(3):305-14. doi: 10.1111/hepr.12352, PMID 24796378.
Fucho R, Martinez L, Baulies A, Torres S, Tarrats N, Fernandez A, Ribas V, Astudillo AM, Balsinde J, Garcia Roves P, Elena M, Bergheim I, Lotersztajn S, Trautwein C, Appelqvist H, Paton AW, Paton JC, Czaja MJ, Kaplowitz N, Fernandez Checa JC, Garcia Ruiz C. ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis. J Hepatol. 2014;61(5):1126-34. doi: 10.1016/j.jhep.2014.06.009. PMID 24946279.
Singh SP, Singh V, Kar N, Chan K. Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: a meta-analysis. Br J Psychiatry. 2010;197(3):174-9. doi: 10.1192/bjp.bp.109.067710, PMID 20807960.
Kenis G, Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol. 2002;5(4):401-12. doi: 10.1017/S1461145702003164, PMID 12466038.
Arteaga Henriquez G, Simon MS, Burger B, Weidinger E, Wijkhuijs A, Arolt V, Birkenhager TK, Musil R, Muller N, Drexhage HA. Low-grade inflammation as a predictor of antidepressant and anti-inflammatory therapy response in MDD patients: a systematic review of the literature in combination with an analysis of experimental data collected in the EU-moodinflame consortium. Front Psychiatry. 2019;10:458. doi: 10.3389/fpsyt.2019.00458, PMID 31354538.
Zhang J, Yue Y, Thapa A, Fang J, Zhao S, Shi W, Yang Z, Li Y, Yuan Y. Baseline serum C-reactive protein levels may predict antidepressant treatment responses in patients with major depressive disorder. J Affect Disord. 2019;250:432-8. doi: 10.1016/j.jad.2019.03.001. PMID 30878656.
Wiedłocha M, Marcinowicz P, Krupa R, Janoska Jazdzik M, Janus M, Dębowska W. Effect of antidepressant treatment on peripheral inflammation markers- A meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2018;80(C):217-26. doi: 10.1016/j.pnpbp.2017.04.026, PMID 28445690. pnpbp.2017.04.026.
Maes M. The immunoregulatory effects of antidepressants. Hum Psychopharmacol. 2001;16(1):95-103. doi: 10.1002/hup.191, PMID 12404604.
Wichit S, Hamel R, Bernard E, Talignani L, Diop F, Ferraris P. Imipramine inhibits Chikungunya virus replication in human skin fibroblasts through interference with intracellular cholesterol trafficking. Sci Rep. 2017;7(1):3145. doi: 10.1038/s41598-017-03316-5, PMID 28600536.
Andersson JA, Sha J, Kirtley ML, Reyes E, Fitts EC, Dann SM, Chopra AK. Combating multidrug-resistant pathogens with host-directed nonantibiotic therapeutics. Antimicrob Agents Chemother. 2018;62(1):e01943-17. doi: 10.1128/AAC.01943-17, PMID 29109161.
Murray HW. Tissue granuloma structure‐function in experimental visceral leishmaniasis. Int J Exp Pathol. 2001;82(5):249-67. doi: 10.1046/j.1365-2613.2001.00199.x. PMID 11703536.
Kaye PM, Svensson M, Ato M, Maroof A, Polley R, Stager S, Zubairi S, Engwerda CR. The immunopathology of experimental visceral leishmaniasis. Immunol Rev. 2004;201(1):239-53. doi: 10.1111/j.0105-2896.2004.00188.x. PMID 15361245.
Mukherjee S, Mukherjee B, Mukhopadhyay R, Naskar K, Sundar S, Dujardin JC, Das AK, Roy S. Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection. PLOS Negl Trop Dis. 2012;6(12):e1987. doi: 10.1371/journal.pntd.0001987. PMID 23301108.
Stager S, Alexander J, Carter KC, Brombacher F, Kaye PM. Both interleukin-4 (IL-4) and IL-4 receptor α signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity. Infect Immun. 2003;71(8):4804-7. doi: 10.1128/IAI.71.8.4804-4807.2003, PMID 12874364.
Stanley AC, Engwerda CR. Balancing immunity and pathology in visceral leishmaniasis. Immunol Cell Biol. 2007;85(2):138-47. doi: 10.1038/sj.icb7100011. PMID 17146466.
Davis RP, Almishri W, Jenne CN, Swain MG. The antidepressant mirtazapine activates hepatic macrophages, facilitating pathogen clearance while limiting tissue damage in mice. Front Immunol. 2020;11:578654. doi: 10.3389/fimmu.2020.578654, PMID 33250892.
Mukherjee S, Pradhan S, Ghosh S, Sundar S, Das S, Mukherjee B, Roy S. Short-course treatment with imipramine entrapped in squalene liposomes results in sterile cure of experimental visceral leishmaniasis induced by antimony resistant Leishmania donovani with increased efficacy. Front Cell Infect Microbiol. 2020;10:595415. doi: 10.3389/fcimb.2020.595415, PMID 33240825.
Zilberstein D, Liveanu V, Gepstein A. Tricyclic drugs reduce proton motive force in Leishmania donovani promastigotes. Biochem Pharmacol. 1990;39(5):935-40. doi: 10.1016/0006-2952(90)90210-c, PMID 1968745.
Kubera M, Kenis G, Bosmans E, Kajta M, Basta Kaim A, Scharpe S, Budziszewska B, Maes M. Stimulatory effect of antidepressants on the production of IL-6. Int Immunopharmacol. 2004;4(2):185-92. doi: 10.1016/j.intimp.2003.11.006. PMID 14996410.
Evans AT, Croft SL. Antileishmanial actions of tricyclic neuroleptics appear to lack structural specificity. Biochem Pharmacol. 1994;48(3):613-6. doi: 10.1016/0006-2952(94)90293-3, PMID 7915114.
Fisar Z. Interactions between tricyclic antidepressants and phospholipid bilayer membranes. Gen Physiol Biophys. 2005;24(2):161-80. PMID 16118470.
Zimmermann N, Zschocke J, Perisic T, Yu S, Holsboer F, Rein T. Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels. Biochem J. 2012;448(1):93-102. doi: 10.1042/BJ20120674, PMID 22880885.
Ahyayauch H, Bennouna M. Interaction of chlorpromazine and imipramine with model membranes. Therapie. 1999;54(5):585-8. PMID 10667094.
Lorente SO, Rodrigues JC, Jimenez Jimenez C, Joyce Menekse M, Rodrigues C, Croft SL, Yardley V, de Luca Fradley K, Ruiz Perez LM, Urbina J, de Souza W, Gonzalez Pacanowska D, Gilbert IH. Novel azasterols as potential agents for the treatment of leishmaniasis and trypanosomiasis. Antimicrob Agents Chemother. 2004;48(8):2937-50. doi: 10.1128/AAC.48.8.2937-2950.2004. PMID 15273104.
Dinesh N, Kaur PK, Swamy KK, Singh S. Mianserin, an antidepressant kills leishmania donovani by depleting ergosterol levels. Exp Parasitol. 2014;144:84-90. doi: 10.1016/j.exppara.2014.06.004.exppara.2014.06.004. PMID 24950381.
Pandey RK, Verma P, Sharma D, Bhatt TK, Sundar S, Prajapati VKJB. High-throughput virtual screening and quantum mechanics approach to develop imipramine analogues as leads against trypanothione reductase of leishmania. Biomed Pharmacother. 2016;83:141-52. doi: 10.1016/j.biopha.2016.06.010, PMID 27470561. biopha.2016.06.010.
Lima ML, Abengozar MA, Nacher-Vazquez M, Martinez-Alcazar MP, Barbas C, Tempone AG, Lopez-Gonzalvez A, Rivas L. Molecular basis of the leishmanicidal activity of the antidepressant sertraline as a drug repurposing candidate. Antimicrob Agents Chemother. 2018;62(12):e01928-18. doi: 10.1128/AAC.01928-18, PMID 30297370.
Singh S, Dinesh N, Kaur PK, Shamiulla B. Ketanserin, an antidepressant, exerts its antileishmanial action via inhibition of 3-hydroxy-3-methylglutaryl coenzyme a reductase (HMGR) enzyme of Leishmania donovani. J Parasitol Res. 2014;113(6):2161-8. doi: 10.1007/s00436-014-3868-y, PMID 24728519.
Alpizar Sosa EA. Polyomic characterization of polyene drug resistance in Leishmania spp. University of Glasgow; 2020.
Kumar A, Chauhan N, Singh S. Understanding the cross-talk of redox metabolism and fe-s cluster biogenesis in leishmania through systems biology approach. Front Cell Infect Microbiol. 2019;9:15. doi: 10.3389/fcimb.2019.00015, PMID 30778378.
Mukhopadhyay R, Mukherjee S, Mukherjee B, Naskar K, Mondal D, Decuypere S. Characterisation of antimony-resistant leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells. Int J Parasitol. 2011;41(13-14):1311-21. doi: 10.1016/j.ijpara.2011.07.013, PMID 21920365. ijpara.2011.07.013.
Reers M, Smith TW, Chen LB. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry. 1991;30(18):4480-6. doi: 10.1021/bi00232a015, PMID 2021638.
Zilberstein D, Dwyer DM. Antidepressants cause lethal disruption of membrane function in the human protozoan parasite leishmania. Science. 1984;226(4677):977-9. doi: 10.1126/science.6505677, PMID 6505677.
Paris C, Loiseau PM, Bories C, Breard J. Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes. Antimicrob Agents Chemother. 2004;48(3):852-9. doi: 10.1128/aacAAC.48.3.852-859.2004, PMID 14982775.
Bezabeh MF, Werbovetz KA, Murthy Krjijo AP, Murthy KVR. Formulation and evaluation of amphotericin b and miltefosine combination nanovesicles. Int J App Pharm. 2021:74-8. doi: 10.22159/ijap.2021v13i3.40605.
Verma NK, Dey CS. Possible mechanism of miltefosine-mediated death of Leishmania donovani. Antimicrob Agents Chemother. 2004;48(8):3010-5. doi: 10.1128/AAC.48.8.3010-3015.2004, PMID 15273114.
Sen S, Roy K, Mukherjee S, Mukhopadhyay R, Roy S. Restoration of IFNγR subunit assembly, IFNγ signaling and parasite clearance in Leishmania donovani infected macrophages: role of membrane cholesterol. PLoOS Pathog. 2011;7(9):e1002229. doi: 10.1371/journal.ppat.1002229.ppat.1002229. PMID 21931549.
Mookerjee Basu J, Mookerjee A, Sen P, Bhaumik S, Sen P, Banerjee S, Naskar K, Choudhuri SK, Saha B, Raha S, Roy S. Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages. Antimicrob Agents Chemother. 2006;50(5):1788-97. doi: 10.1128/AAC.50.5.1788-1797.2006, PMID 16641451.
Luque Ortega JR, Rivas L. Characterization of the leishmanicidal activity of antimicrobial peptides. Antimicrob Peptid Methods Mol Biol Springer. 2010;618:393-420. doi: 10.1007/978-1-60761-594-1_25, PMID 20094878.
Pan AA, Duboise SM, Eperon S, Rivas L, Hodgkinson V, Traub‐Cseko Y. Developmental life cycle of leishmania-cultivation and characterization of cultured extracellular amastigotes 1. J Eukaryot Microbiol. 1993;40(2):213-23. doi: 10.1111/j.1550-7408.1993.tb04906.x.
Saunders EC, Ng WW, Kloehn J, Chambers JM, Ng M, McConville MJ. Induction of stringent metabolic response in intracellular stages of Leishmania mexicana leads to increased dependence on mitochondrial metabolism. PLoOS Pathog. 2014;10(1):e1003888. doi: 10.1371/journal.ppat.1003888.ppat.1003888. PMID 24465208.
Basu R, Bhaumik S, Basu JM, Naskar K, De T, Roy S. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and-resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis. J Immunol. 2005;174(11):7160-71. doi: 10.4049/jimmunol.174.11.7160, PMID 15905560.
Akhoundi M, Kuhls K, Cannet A, Votypka J, Marty P, Delaunay P, Sereno D. A historical overview of the classification, evolution, and dispersion of Leishmania parasites and sandflies. PLoOS Negl Trop Dis. 2016;10(3):e0004349. doi: 10.1371/journal.pntd.0004349.pntd.0004349. PMID 26937644.
Shaw J, Pratlong F, Floeter Winter L, Ishikawa E, El Baidouri F, Ravel C, Dedet JP. Characterization of leishmania (Leishmania) waltoni n. sp. (Kkinetoplastida: Trypanosomatidae), the parasite responsible for diffuse cutaneous leishmaniasis in the dominican republic. Am J Trop Med Hyg. 2015;93(3):552-8. doi: 10.4269/ajtmh.14-0774, PMID 26149864.
Espinosa OA, Serrano MG, Camargo EP, Teixeira MMG, Shaw JJ. An appraisal of the taxonomy and nomenclature of trypanosomatids presently classified as Leishmania and Endotrypanum. Parasitology. 2018;145(4):430-42. doi: 10.1017/S0031182016002092, PMID 27976601.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Sugato Banerjee, Keya Mallick
This work is licensed under a Creative Commons Attribution 4.0 International License.
